334 filings
Page 6 of 17
8-K
o60ak csm
27 Apr 22
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
8:30am
8-K
mrq3zksb9 0qf0th
12 Apr 22
Regulation FD Disclosure
4:01pm
8-K/A
dcrdro
1 Apr 22
Entry into a Material Definitive Agreement
4:01pm
8-K
lqoe eazz
31 Mar 22
Entry into a Material Definitive Agreement
7:20pm
8-K
1y803 3zaf
17 Feb 22
T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results
5:30pm
8-K
nktf8ye2o2j1q
11 Jan 22
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results
9:15am
8-K
qn55dcy86etkppj q3d
9 Nov 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:07pm
8-K
vm7a55sek a11c1q2
5 Nov 21
T2 Biosystems Announces Third Quarter 2021 Financial Results
4:01pm
8-K
1zieyq62rxx9m
19 Oct 21
Departure of Directors or Certain Officers
4:31pm
8-K
yfh5rk4xibkhljzd1pdy
4 Oct 21
Entry into a Material Definitive Agreement
4:29pm
8-K
12hptey32a5
8 Sep 21
Entry into a Material Definitive Agreement
4:06pm
8-K
cwfq58
10 Aug 21
T2 Biosystems Announces Second Quarter 2021 Financial Results
4:01pm
8-K
0gw3f1 3n1
23 Jul 21
Departure of Directors or Certain Officers
4:00pm
DEFA14A
jhd89
13 Jul 21
Additional proxy soliciting materials
4:00pm
8-K
njs9yy
28 Jun 21
Departure of Directors or Certain Officers
4:00pm
DEFA14A
qwwakx1 sdfvig2t
11 Jun 21
Additional proxy soliciting materials
9:18am
SD
nkn2tajxyat3h46ud
1 Jun 21
Conflict minerals disclosure
4:00pm